eIF1AY inhibitors represent a class of compounds that specifically target and inhibit the activity of the eukaryotic translation initiation factor 1A (eIF1A), which is essential in the initiation phase of protein synthesis. eIF1A plays a crucial role in stabilizing the binding of the initiator tRNA to the small ribosomal subunit and promoting the proper scanning of the messenger RNA (mRNA) for the start codon. By inhibiting eIF1A, these compounds disrupt the normal initiation process, leading to a decrease in overall protein synthesis. This inhibition can have significant effects on cellular processes, as protein synthesis is fundamental to cell growth, division, and response to environmental stimuli.
The mechanism of action of eIF1AY inhibitors involves binding to specific sites on the eIF1A protein, thereby preventing its interaction with the ribosomal subunits and other initiation factors. This binding can induce conformational changes in eIF1A, rendering it incapable of performing its function in the initiation complex. The development and study of eIF1AY inhibitors have provided valuable insights into the molecular dynamics of translation initiation and the regulatory mechanisms controlling protein synthesis. These compounds have also been used as tools in research to dissect the roles of eIF1A in various cellular pathways and to understand the broader implications of translational control in cellular physiology. The study of eIF1AY inhibitors continues to be a dynamic field, contributing to our understanding of the intricate processes that govern gene expression at the translational level.
Items 1 to 10 of 16 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | ¥372.00 ¥1151.00 | 87 | |
Salubrinal抑制eIF2α去磷酸化,延长磷酸化时间,从而减少翻译起始。 | ||||||
Guanabenz HCl | 23113-43-1 | sc-507500 | 100 mg | ¥2719.00 | ||
Guanabenz通过激活eIF2α磷酸酶PP1来减少eIF2α的磷酸化,从而允许翻译正常进行。 | ||||||
GSK 2606414 | 1337531-36-8 | sc-490182 sc-490182A | 5 mg 25 mg | ¥1805.00 ¥6329.00 | ||
GSK2606414抑制PERK的活性,后者是一种磷酸化eIF2α的激酶,从而降低eIF2α的磷酸化水平。 | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | ¥857.00 ¥2437.00 | 101 | |
顺铂通过造成DNA损伤、触发综合应激反应和eIF2α磷酸化,间接影响eIF2α。 | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | ¥1061.00 ¥3937.00 | 114 | |
Thapsigargin诱导ER应激,激活PERK并导致eIF2α磷酸化,从而抑制蛋白质合成。 | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | ¥361.00 ¥1918.00 ¥4344.00 | 63 | |
依托泊苷导致DNA损伤,从而可能引发细胞应激反应,从RNAi途径转移细胞资源,从而下调eIF2C2。 | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | ¥406.00 ¥1681.00 | 11 | |
5-氟尿嘧啶作为一种嘧啶类似物,可能会破坏核苷酸代谢。这种破坏会通过阻碍RNA合成间接影响RNAi组件,导致eIF2C2水平下降。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | ¥1489.00 ¥12004.00 | 115 | |
硼替佐米抑制蛋白酶体,影响蛋白质的更新。这可能会破坏细胞蛋白质的平衡,从而降低eIF2C2的稳定性或合成。 | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | ¥824.00 ¥2685.00 ¥8089.00 ¥28453.00 ¥241660.00 | 53 | |
放线菌素D通过插入DNA来阻碍RNA合成。这会导致RNA衍生过程的普遍下调,其中可能包括eIF2C2水平的降低。 | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | ¥451.00 ¥925.00 ¥2888.00 | 127 | |
环己酰胺通过抑制蛋白质合成,可能会阻止新的eIF2C2分子的产生,导致eIF2C2的净减少,因为现有蛋白质会降解。 |